MAGI, LUDOVICA
 Distribuzione geografica
Continente #
NA - Nord America 482
EU - Europa 231
AS - Asia 51
AF - Africa 7
SA - Sud America 6
OC - Oceania 1
Totale 778
Nazione #
US - Stati Uniti d'America 470
IT - Italia 104
IE - Irlanda 62
SE - Svezia 25
SG - Singapore 19
IN - India 17
CA - Canada 11
CN - Cina 9
FI - Finlandia 7
TG - Togo 7
AR - Argentina 5
BE - Belgio 5
GB - Regno Unito 5
BG - Bulgaria 4
DE - Germania 4
SI - Slovenia 4
CH - Svizzera 3
PH - Filippine 3
UA - Ucraina 3
PK - Pakistan 2
RO - Romania 2
AU - Australia 1
BR - Brasile 1
FR - Francia 1
LI - Liechtenstein 1
MX - Messico 1
MY - Malesia 1
NL - Olanda 1
Totale 778
Città #
Fairfield 114
Dublin 62
Chandler 59
Ashburn 46
Rome 29
Woodbridge 23
Houston 16
New York 15
Cambridge 14
Princeton 13
Wilmington 12
Lawrence 11
Seattle 11
Singapore 11
Millbury 10
San Paolo di Civitate 10
Ann Arbor 9
Fara in Sabina 7
Lomé 7
Milan 7
Ottawa 7
Beijing 5
Brussels 5
Calvanico 5
Federal 5
Grottammare 5
Helsinki 5
Falls Church 4
Ljubljana 4
Shanghai 4
Sofia 4
Andover 3
Boardman 3
Boston 3
Cebu City 3
Naples 3
San Diego 3
Bremen 2
Catania 2
Islamabad 2
Lappeenranta 2
London 2
Marino 2
Palermo 2
Québec 2
Toronto 2
Vevey 2
Americana 1
Bari 1
Bern 1
Bologna 1
Bühl 1
Deruta 1
Des Moines 1
Hyderabad 1
Kilburn 1
Los Angeles 1
Mannheim 1
Messina 1
Norwalk 1
Oldham 1
Perugia 1
Reggio Calabria 1
Sacramento 1
San Mateo 1
Schaan 1
Sydney 1
Syracuse 1
West Roxbury 1
Totale 599
Nome #
CT texture analysis of liver metastases in PNETs versus NPNETs. correlation with histopathological findings 93
[18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia 84
Role of combined [68Ga]Ga-DOTA-SST analogues and [18F]FDG PET/CT in the management of GEP-NENs. a systematic review 81
[18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia 77
Occurrence of exocrine pancreatic insufficiency in patients with advanced neuroendocrine tumors treated with somatostatin analogs 69
Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors 68
Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center 62
Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia. A Systematic Review 50
Octreotide long-acting release (LAR) in combination with other therapies for treatment of neuroendocrine neoplasia. A systematic review 41
Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia 38
CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors 37
Efficacy of lutetium-peptide receptor radionuclide therapy in inducing prolonged tumour regression in small-bowel veuroendocrine tumours. A case of favourable response to retreatment after Initial objective response 34
Tumor heterogenity in gastro-entero-pancreatic neuroendocrine neoplasia 29
What gastroenterologists should know about carcinoid syndrome 28
Management of functional pancreatic neuroendocrine neoplasms 23
Reply to Dr. Hall and coworkers 23
Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia 17
The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors. A Systematic Review and Meta-Analysis 14
Totale 868
Categoria #
all - tutte 3.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202053 0 0 0 0 0 0 9 8 16 10 9 1
2020/202186 4 0 14 8 2 0 0 4 12 15 9 18
2021/2022278 2 3 2 6 15 8 3 27 70 30 95 17
2022/2023276 28 52 13 17 41 17 6 14 69 3 14 2
2023/2024170 10 21 9 22 18 25 14 17 1 3 27 3
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 868